Cargando…
Challenges for heart disease stem cell therapy
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. The use of stem cells to improve recovery of the injured heart after myocardial infarction (MI) is an important emerging therapeutic strategy. However, recent reviews of clinical trials of stem cell therapy for MI and ischemic...
Autores principales: | Hoover-Plow, Jane, Gong, Yanqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295632/ https://www.ncbi.nlm.nih.gov/pubmed/22399855 http://dx.doi.org/10.2147/VHRM.S25665 |
Ejemplares similares
-
The Plasminogen System in Regulating Stem Cell Mobilization
por: Gong, Yanqing, et al.
Publicado: (2012) -
Does plasmin have anticoagulant activity?
por: Hoover-Plow, Jane
Publicado: (2010) -
EMILIN2 Regulates Platelet Activation, Thrombus Formation, and Clot Retraction
por: Huang, Menggui, et al.
Publicado: (2015) -
Progress and Challenges of Amniotic Fluid Derived Stem Cells in Therapy of Ischemic Heart Disease
por: Fang, Yi-Hsien, et al.
Publicado: (2020) -
EMILIN2 (Elastin microfibril interface located protein), potential modifier of thrombosis
por: Sa, Qila, et al.
Publicado: (2011)